Impact of Pulmonary Rehabilitation on Fatigue and Quality of Life in Patients of Interstitial Lung Disease
Abstract
Individuals with interstitial lung diseases (ILDs) often experience debilitating fatigue, impacting their quality of life. Pulmonary rehabilitation (PR), comprising tailored exercise, education, and behaviour change, aims to improve physical and psychological conditions in ILD patients. Evaluating fatigue and quality of life pre- and post-pulmonary rehabilitation provides insights into its effectiveness in enhancing patient outcomes. Following ethical approval, an exploratory cross-sectional study was conducted at the Department of Respiratory Medicine, Chettinad Hospital and Research Institute. The study enrolled 73 ILD patients admitted between August 2022 and August 2023. Comprehensive pulmonary function assessments and medical histories were obtained from reliable sources and were assessed with questionnaires like the Fatigue Assessment Scale (FAS) for fatigue and St. George Respiratory Questionnaire (SGRQ) for quality of life before and after a 6-month individualized home-based pulmonary rehabilitation program. Seventy-three (73) patients were enrolled in the study. The age group with the highest number of patients was between 50 – 60 years (40%), with a male predominance of 60 % (44). Independent samples of different tools in the research and their mean values were compared using the T-test. This study illustrates the considerable link between the ILD cases for FAS and SGRQ with statistically significant differences in FAS and SGRQ between time durations, at 3 and 6 months duration, indicating improvement in fatigue and quality of life in those patients at a 3 and 6-month duration (p <0.001). The assessment showed a significant decline in fatigue levels (p<0.001) and a marked betterment in the overall quality of life (p<0.0066) among patients after participating in Pulmonary Rehabilitation when compared with FVC severity. These findings underscore the importance of integrating rehabilitation programs into the comprehensive care of these patients to improve their overall health and well-being.
References
Adegunsoye, A., Neborak, J. M., Zhu, D., Cantrill, B., Garcia, N., Oldham, J. M., Noth, I., Vij, R., Kuzniar, T. J., Bellam, S. K., Strek, M. E., & Mokhlesi, B. (2020). CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest, 158(4), 1701–1712. https://doi.org/10.1016/j.chest.2020.04.067
Aronson, K.I., & Suzuki, A. (2021). Health Related Quality of Life in Interstitial Lung Disease: Can We Use the Same Concepts Around the World? Frontiers in Medicine, 8, 745908. https://doi.org/10.3389/fmed.2021.745908
Boyer, F., Pineau, C., Haroutel, D., Ramalanjoana, M., & Rapin, A. (2017). Pulmonary rehabilitation practice guidelines and chronic pulmonary diseases. Annals of Physical and Rehabilitation Medicine, 60, e104. https://doi.org/10.1016/j.rehab.2017.07.158
de Vries, J., Michielsen, H., Van Heck, G. L., & Drent, M. (2004). Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS). British Journal of Health Psychology, 9(3), 279–291. Portico. https://doi.org/10.1348/1359107041557048
Dowman, L., Hill, C. J., May, A., & Holland, A. E. (2021). Pulmonary rehabilitation for interstitial lung disease. The Cochrane Database of Systematic Reviews, 2(2), CD006322. https://doi.org/10.1002/14651858.CD006322.pub4
Fraser, S., Zhou, S., James, N., Allgar, V., Crooks, M., & Hart, S. (2018). P162 The St George’s respiratory questionnaire tracks sarcoidosis severity over time: a prospective longitudinal study. Thorax, 73, A190. https://doi.org/10.1136/thorax-2018-212555.320
Guenther, A., Krauss, E., Tello, S., Wagner, J., Paul, B., Kuhn, S., Maurer, O., Heinemann, S., Costabel, U., Barbero, M. A. N., Müller, V., Bonniaud, P., Vancheri, C., Wells, A., Vasakova, M., Pesci, A., Sofia, M., Klepetko, W., Seeger, W., Drakopanagiotakis, F., … Crestani, B. (2018). The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respiratory Research, 19(1), 141. https://doi.org/10.1186/s12931-018-0845-5
Holland, A. E., Hill, C. J., Glaspole, I., Goh, N., & McDonald, C. F. (2012). Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respiratory medicine, 106(3), 429–435. https://doi.org/10.1016/j.rmed.2011.11.014
Ibn Yacoub, Y., Amine, B., Bensabbah, R., & Hajjaj-Hassouni, N. (2012). Assessment of fatigue and its relationships with disease-related parameters in patients with systemic sclerosis. Clinical Rheumatology, 31(4), 655–660. https://doi.org/10.1007/s10067-011-1906-z
Jeganathan, N., & Sathananthan, M. (2021). The prevalence and burden of interstitial lung diseases in the USA. ERJ Open Research, 8(1), 00630-2021. https://doi.org/10.1183/23120541.00630-2021
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991). The St George's Respiratory Questionnaire. Respiratory Medicine, 85(Suppl B), 25–37. https://doi.org/10.1016/s0954-6111(06)80166-6
Kahlmann, V., Moor, C. C., & Wijsenbeek, M. S. (2020). Managing Fatigue in Patients With Interstitial Lung Disease. Chest, 158(5), 2026–2033. https://doi.org/10.1016/j.chest.2020.04.047
Kaul, B., Cottin, V., Collard, H. R., & Valenzuela, C. (2021). Variability in Global Prevalence of Interstitial Lung Disease. Frontiers in Medicine, 8, 751181. https://doi.org/10.3389/fmed.2021.751181
Kawano-Dourado, L., Glassberg, M. K., Assayag, D., Borie, R., & Johannson, K. A. (2021). Sex and gender in interstitial lung diseases. European Respiratory Review : an official journal of the European Respiratory Society, 30(162), 210105. https://doi.org/10.1183/16000617.0105-2021
Kølner-Augustson, L., Skovhus Prior, T., Skivild, V., Aalestrup, A., & Bendstrup, E. (2019). Fatigue changes in IPF patients measured by the Fatigue Assessment Scale during antifibrotic treatment. Idiopathic Interstitial Pneumonias. https://doi.org/10.1183/13993003.congress-2019.pa1331
Kumar, V. (2013). Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease. Pulmonary and Critical Care Medicine: Chronic Obstructive Pulmonary Diseases, pp. 195–195. https://doi.org/10.5005/jp/books/12063_13
Lanza, M., Meoli, I., Cauteruccio, R., Stefanelli, F., Di Giorgio, A., Annunziata, A., & Fiorentino, G. (2019). Short and long-term effects of pulmonary rehabilitation in Idiopatic Pulmonary Fibrosis: The evidence of benefits of exercise training. Rehabilitation and Chronic Care. https://doi.org/10.1183/13993003.congress-2019.pa678
Lubin, M., Chen, H., Elicker, B., Jones, K. D., Collard, H. R., & Lee, J. S. (2014). A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Chest, 145(6), 1333–1338. https://doi.org/10.1378/chest.13-1984
Mendes, R. G., Castello-Simões, V., Trimer, R., Garcia-Araújo, A. S., Gonçalves Da Silva, A. L., Dixit, S., Di Lorenzo, V. A. P., Archiza, B., & Borghi-Silva, A. (2021). Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety. Frontiers in rehabilitation sciences, 2, 744102. https://doi.org/10.3389/fresc.2021.744102
Mueller-Mang, C., Ringl, H., & Herold, C. (2017). Interstitial Lung Diseases. Medical Radiology, pp. 261–288. https://doi.org/10.1007/174_2017_151
Nakazawa, A., Cox, N. S., & Holland, A. E. (2017). Current best practice in rehabilitation in interstitial lung disease. Therapeutic Advances in Respiratory Disease, 11(2), 115–128. https://doi.org/10.1177/1753465816676048
Nelsen, L. M., Kimel, M., Murray, L. T., Ortega, H., Cockle, S. M., Yancey, S. W., Brusselle, G., Albers, F. C., & Jones, P. W. (2017). Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma. Respiratory Medicine, 126, 32–38. https://doi.org/10.1016/j.rmed.2017.02.021
Pumar, M. I., Roll, M., Fung, P., Rolls, T. A., Walsh, J. R., Bowman, R. V., Fong, K. M., & Yang, I. A. (2019). Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. Journal of Thoracic Disease, 11(Suppl 17), S2238–S2253. https://doi.org/10.21037/jtd.2019.10.23
Rajala, K., Lehto, J. T., Sutinen, E., Kautiainen, H., Myllärniemi, M., & Saarto, T. (2017). mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis. ERJ Open Research, 3(4), 00084-2017. https://doi.org/10.1183/23120541.00084-2017
Reddy, N. S., & Khanaa, V. (2023). Diagnosing and categorizing of pulmonary diseases using Deep learning conventional Neural network. Int. J. Exp. Res. Rev., 31(Spl Volume), 12-22. https://doi.org/10.52756/10.52756/ijerr.2023.v31spl.002
Ryerson, C. J., Cayou, C., Topp, F., Hilling, L., Camp, P. G., Wilcox, P. G., Khalil, N., Collard, H. R., & Garvey, C. (2014). Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respiratory Medicine, 108(1), 203–210. https://doi.org/10.1016/j.rmed.2013.11.016
Shenoy, M. A., & Spiegler, P. (2022). Pulmonary rehabilitation. Pathy’s Principles and Practice of Geriatric Medicine, pp. 555–560. https://doi.org/10.1002/9781119484288.ch43
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D., Pitta, F., Sewell, L., Raskin, J., Bourbeau, J., Crouch, R., Franssen, F. M., Casaburi, R., Vercoulen, J. H., Vogiatzis, I., Gosselink, R., … ATS/ERS Task Force on Pulmonary Rehabilitation (2013). An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine, 188(8), e13–e64. https://doi.org/10.1164/rccm.201309-1634ST
Swigris, J. J., Wilson, H., Esser, D., Conoscenti, C. S., Stansen, W., Kline Leidy, N., & Brown, K. K. (2018). Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials. BMJ Open Respiratory Research, 5(1), e000278. https://doi.org/10.1136/bmjresp-2018-000278
Wong, A. W., Ryerson, C. J., & Guler, S. A. (2020). Progression of fibrosing interstitial lung disease. Respiratory Research, 21(1), 32. https://doi.org/10.1186/s12931-020-1296-3
Yohannes A. M. (2020). Depression and anxiety in patients with interstitial lung disease. Expert Review of Respiratory Medicine, 14(9), 859–862. https://doi.org/10.1080/17476348.2020.1776118
Copyright (c) 2024 International Academic Publishing House (IAPH)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
